Insulin-like growth factor 1 prevents atherosclerosis progression in aged apolipoprotein E-deficient mice.

被引:0
|
作者
Higashi, Y. [1 ]
Sukhanov, S. [1 ]
Shai, S.-Y. [1 ]
Titterington, J. [1 ]
Delafontaine, P. [1 ]
机构
[1] Tulane Univ, Sch Med, Cardiol Sect, New Orleans, LA 70112 USA
关键词
D O I
10.1097/00042871-200701010-00710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S279 / S279
页数:1
相关论文
共 50 条
  • [31] Continuous Hypobaric Hypoxia may Promote Atherosclerosis Progression in Apolipoprotein E-deficient Mice
    Luo, Shouming
    Ma, Xiaogen
    Wu, Weiqiang
    Lin, Shu
    Li, Mindian
    Zhang, Zhihui
    Zhu, Ping
    Song, Zhiyuan
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2023, 20 (07): : 849 - 857
  • [32] The proatherosclerotic function of BCAT1 in atherosclerosis development of aged-apolipoprotein E-deficient mice
    Tan, Lili
    Lu, Jie
    Zhang, Chunyang
    Meng, Liang
    Zhu, Qi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 631 : 93 - 101
  • [33] C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
    Paul, A
    Ko, KWS
    Li, L
    Yechoor, V
    McCrory, MA
    Szalai, AJ
    Chan, L
    CIRCULATION, 2004, 109 (05) : 647 - 655
  • [34] A mushroom, white bunashimeji (Hypsizigus marmoreus) prevents the development of atherosclerosis in apolipoprotein E-deficient mice
    Ikeda, M.
    Mori, K.
    Kobayashi, C.
    Ohmori, Y.
    Tomita, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 436 - 436
  • [35] Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice
    Willner, EL
    Tow, B
    Buhman, KK
    Wilson, M
    Sanan, DA
    Rudel, LL
    Farese, RV
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) : 1262 - 1267
  • [36] Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
    Alejandra Mendez-Lara, Karen
    Letelier, Nicole
    Farre, Nuria
    Diarte-Anazco, Elena M. G.
    Nieto-Nicolau, Nuria
    Rodriguez-Millan, Elisabeth
    Santos, David
    Pallares, Victor
    Carles Escola-Gil, Joan
    Vazquez del Olmo, Tania
    Lerma, Enrique
    Camacho, Mercedes
    Casaroli-Marano, Ricardo P.
    Valledor, Annabel F.
    Blanco-Vaca, Francisco
    Julve, Josep
    ANTIOXIDANTS, 2020, 9 (11) : 1 - 15
  • [37] Studies on the pathogenesis of atherosclerosis using apolipoprotein E-deficient mice
    Zhang, SH
    Reddick, RL
    Maeda, N
    DRUGS AFFECTING LIPID METABOLISM: RISK FACTORS AND FUTURE DIRECTIONS, 1996, 10 : 255 - 261
  • [38] Supplementation of tetrahydrobiopterin inhibits atherosclerosis in apolipoprotein E-deficient mice
    Ozaki, M
    Kawashima, S
    Yamashita, T
    Namiki, M
    Hirase, T
    Inoue, N
    Hirata, K
    Yokoyama, M
    CIRCULATION, 2002, 106 (19) : 70 - 70
  • [39] Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice
    Desai, Anjali
    Zhao, Ying
    Warren, Jeffrey S.
    CARDIOVASCULAR PATHOLOGY, 2008, 17 (04) : 233 - 240
  • [40] Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice
    Jun, Jonathan
    Reinke, Christian
    Bedja, Djahida
    Berkowitz, Dan
    Bevans-Fonti, Shannon
    Li, Jianguo
    Barouch, Lili A.
    Gabrielson, Kathleen
    Polotsky, Vsevolod Y.
    ATHEROSCLEROSIS, 2010, 209 (02) : 381 - 386